SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SLS shares experienced downward pressure alongside widespread community debate triggered by third-party survival models shared on social media, which challenged the previously high success expectations for the REGAL trial. While some traders interpreted the decline as a coordinated manipulation effort to shake out weak hands, others viewed it as a necessary rebalancing, with many long-term shareholders emphasizing that the core clinical thesis and trial dynamics remain unchanged.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is facing downward price pressure driven by investor disappointment regarding the efficacy data for its sonelokimab therapy in psoriatic arthritis, as well as concerns over the company's decision to pursue a solo commercialization strategy involving potential share dilution. While some traders view the current stock price as an attractive buying opportunity due to the company's strong cash position and the upcoming FDA filing for hidradenitis suppurativa, others are skeptical of management's communication and the drug's ability to compete in a crowded market.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers Health is currently experiencing high volatility driven by speculation regarding potential peptide product launches and broader global expansion, alongside community debate over short interest and institutional activity. Investors remain divided, with some highlighting the company's long-term growth potential and data-driven platform, while others focus on regulatory risks and intense fluctuations in trading volume.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklo is trending due to significant community backlash and price decline following the company's announcement of a new $1 billion at-the-market equity offering program. Traders are debating the necessity of this dilution given the company's existing cash balance, while expressing frustration over recent insider selling and the lack of immediate commercial revenue.

NuScale Power Corp. provides proprietary and innovative advanced small modular reactor (SMR) nuclear technology, with a mission to help power the global energy transition by delivering safe, scalable, and reliable carbon-free energy. Its products include VOYGR SMR Plants and Energy Exploration (E2) Centers. The company was founded by José N. Reyes in 2007 and is headquartered in Corvallis, OR.

NuScale Power Corporation - Ordinary Shares - Class A

NuScale Power Corp

NuScale Power is trading lower following a downgrade by UBS, which cited concerns regarding a lengthy project build timeline, limited customer commitments, and projected future cash burn. While retail traders continue to debate the company's long-term commercial execution and project viability, many market participants view the pullback as an overreaction to analyst sentiment rather than a fundamental change in the sector's nuclear power thesis.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Conversation around DJT is dominated by intense political polarization, centering on criticisms of Donald Trump's conduct during the 25th anniversary of 9/11 and skepticism regarding his campaign pledge to issue a financial dividend to citizens. Traders are divided between supporters defending his leadership and critics highlighting concerns over his campaign promises, potential ethical issues, and the company's financial performance.

Amplify Commodity Trust - Breakwave Tanker Shipping ETF

Breakwave Tanker Shipping ETF

Breakwave Tanker Shipping ETF is trending as traders react to its significant year-to-date gains and ongoing geopolitical instability in the Middle East, particularly around the Strait of Hormuz. Community discussion centers on the potential for continued upside driven by shipping rate volatility and the scarcity of tanker capacity, alongside debate regarding the risks of entering the trade at current parabolic price levels.

Select Sector SPDR Trust (The) - State Street Energy Select Sector SPDR ETF

Energy Select Sector SPDR Fund

The energy sector is trending due to rising crude prices driven by escalating tensions in the Middle East and concerns over supply disruptions at the Strait of Hormuz. While some traders are expressing uncertainty and debating the impact of ongoing geopolitical conflict and potential diplomatic negotiations on future performance, the sector continues to show relative strength with significant year-to-date gains.

Lumentum Holdings, Inc. engages in the provision of optical and photonic products. It operates through the Cloud and Networking, and Industrial Tech segments. The Cloud and Networking segment refers to a portfolio of optical and photonic components, modules, and subsystems. The Industrial Tech segment includes solid-state lasers, kilowatt-class fiber lasers, ultrafast lasers, diode lasers, and gas lasers. The company was founded in 1979 and is headquartered in San Jose, CA.

Lumentum Holdings Inc

Lumentum is trending following an earnings report that exceeded analyst expectations for both revenue and EPS, coupled with upward-revised guidance driven by robust demand for optical networking and AI infrastructure. Despite the strong results, the stock is experiencing high volatility as traders react to the news and ongoing uncertainty regarding macroeconomic conditions.

Listed Funds Trust - Roundhill Magnificent Seven ETF

Roundhill Magnificent Seven ETF

The Roundhill Magnificent Seven ETF is garnering attention as investors debate whether the recent underperformance of mega-cap tech stocks represents a healthy rotational correction or a structural breakdown. Traders are closely monitoring key support levels and moving averages while weighing the impact of hyperscaler capital expenditure spending against shifting market leadership.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

QHSLab, Inc. operates as a medical device technology and software as a service company. It focuses on enabling primary care physicians to increase their revenues by providing them with relevant, value-based tools to evaluate, and treat chronic disease through reimbursable procedures. Its products will enable physicians to diagnose and treat patients with chronic diseases which they historically have referred to specialists. The company was founded on September 1, 1983 and is headquartered in West Palm Beach, FL.

QHSLab Inc - Ordinary Shares - Class A

Neutral Sentiment

President Trump has promised to issue a $5,000 "dividend" check to every adult American citizen if the Republican Party wins control of both the House and the Senate in the upcoming midterm elections, though the proposal would require congressional approval and follows his earlier $2,000 tariff-dividend plan, which stalled after the Supreme Court struck down much of his tariff authority. Do you think the $5,000 dividend check actually happens? Vote and explain your reasoning in the comments.

Trump has pledged a $5,000 &quot;dividend&quot; check to every adult American citizen if Republicans win control of both the House and Senate in the midterms. Do you think it actually happens?

Stocktwits

Trump has pledged a $5,000 "dividend" check to every adult American citizen if Republicans win control of both the House and Senate in the midterms. Do you think it actually happens?

Feed

News

Sentiment

Fundamentals

Info

USAQ QHSLab Inc

Fundamentals

Latest USAQ News